Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sara Medina-Bielski"'
Autor:
William R. Schwan, Rebecca Polanowski, Paul M. Dunman, Sara Medina-Bielski, Michelle Lane, Marc Rott, Lauren Lipker, Amy Wescott, Aaron Monte, James M. Cook, Douglas D. Baumann, V.V.N. Phani Babu Tiruveedhula, Christopher M. Witzigmann, Cassandra Mikel, Md Toufiqur Rahman
Publikováno v:
Antibiotics, Vol 6, Iss 3, p 17 (2017)
The mechanism of action for a new lead stilbene compound coded SK-03-92 with bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) is unknown. To gain insight into the killing process, transcriptional profiling was performe
Externí odkaz:
https://doaj.org/article/2b79c41766a14937a9b1eef60589aabb
Publikováno v:
Mayo Clinic Proceedings. 97:1014-1019
Publikováno v:
Journal of the American Medical Directors Association. 24:B11
Publikováno v:
Journal of the American Medical Directors Association. 24:B10
Publikováno v:
Journal of the American Medical Directors Association. 24:B12
Autor:
Marc Rott, Christopher M. Witzigmann, Lauren Lipker, Michelle Lane, V. V. N. Phani Babu Tiruveedhula, William R. Schwan, Douglas D Baumann, Rebecca Polanowski, Paul M. Dunman, Cassandra Mikel, Sara Medina-Bielski, Toufiqur Rahman, Amy Wescott, James M. Cook, Aaron Monte
Publikováno v:
Antibiotics
Antibiotics; Volume 6; Issue 3; Pages: 17
Antibiotics, Vol 6, Iss 3, p 17 (2017)
Antibiotics; Volume 6; Issue 3; Pages: 17
Antibiotics, Vol 6, Iss 3, p 17 (2017)
The mechanism of action for a new lead stilbene compound coded SK-03-92 with bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA) is unknown. To gain insight into the killing process, transcriptional profiling was performe
Autor:
Christopher M. Witzigmann, V. V. N. Phani Babu Tiruveedhula, James M. Cook, Sara Medina-Bielski, Ranjit Verma, Marc Rott, Rebecca Polanowski, William L. Close, Michelle Lane, Aaron Monte, Jeffrey R. Deschamps, William R. Schwan, David R. Sherman, M. Shahjahan Kabir
Publikováno v:
Bioorganicmedicinal chemistry. 21(24)
The alarming increase in bacterial resistance over the last decade along with a dramatic decrease in new treatments for infections has led to problems in the healthcare industry. Tuberculosis (TB) is caused mainly by Mycobacterium tuberculosis which